Multicentre prospective study to evaluate effectiveness and safety of gel-forming and hyaluronic-acid containing chewable tablets as add-on treatment in patients with gastroesophageal reflux disease (GERD) symptoms and unsatisfying proton pump inhibitor therapy
Gastroesophageal reflux disease (GERD) is a common disease which in the majority of patients is treated with proton pump inhibitors (PPI). However, up to 45% of the patients remain symptomatic on a standard do...
Source: BMC Gastroenterology - Category: Gastroenterology Authors: Manfred Gross, Dennis Neuschwander, Lisa Steffens, J örn Thomsen and Kristina Röschmann-Doose Tags: Research Source Type: research
More News: Acid Reflux | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Proton Pump Inhibitors PPIs | Study